International Seaway Trading Corp. v. Walgreens Corp.

589 F.3d 1233, 93 U.S.P.Q. 2d (BNA) 1001, 2009 U.S. App. LEXIS 27648, 2009 WL 4842608
CourtCourt of Appeals for the Federal Circuit
DecidedDecember 17, 2009
Docket2009-1237
StatusPublished
Cited by44 cases

This text of 589 F.3d 1233 (International Seaway Trading Corp. v. Walgreens Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
International Seaway Trading Corp. v. Walgreens Corp., 589 F.3d 1233, 93 U.S.P.Q. 2d (BNA) 1001, 2009 U.S. App. LEXIS 27648, 2009 WL 4842608 (Fed. Cir. 2009).

Opinions

DYK, Circuit Judge.

Plaintiff-Appellant International Seaway Trading Corporation (“Seaway”) filed suit against Walgreens Corporation (“Wal-greens”) and Touchsport Footwear USA, Inc. (“Touchsport”) claiming infringement of Seaway’s patents, U.S. Design Patents Nos. D529,263 (“the '263 patent”), D545,-032 (“the '032 patent”), and D545,033 (“the '033 patent”). The district court granted summary judgment for defendants, finding that the claims of the asserted patents were invalid under 35 U.S.C. § 102 as anticipated by a patent assigned to Crocs, Inc. (“Crocs”), U.S. Design Patent No. D517,789 (“the Crocs '789 patent”). Int’l Seaway Trading Corp. v. Walgreens Corp., 599 F.Supp.2d 1307, 1319 (S.D.Fla.2009).

On appeal, Seaway contends that the district court erred by basing its invalidity determination solely on the ordinary observer test and by failing to apply the point of novelty test. We agree with the district court that the point of novelty test should not be utilized for anticipation, and that only the ordinary observer test applies. However, while we conclude that the exterior appearance of the patented designs would be substantially similar to the prior art in the eyes of an ordinary observer, we conclude that the district court erred in failing to compare the insoles of the patents-in-suit with the prior art from the perspective of the ordinary observer. Accordingly, we affirm-in-part, vacate-in-part, and remand.

BACKGROUND

Plaintiff-Appellant Seaway is an Ohio corporation that acts as a buyer’s agent and/or importer of footwear to mass merchandise retailers, as well as to footwear, apparel, and sporting goods stores. Seaway also creates its own shoe and boot designs and pursues design patents for them. Defendantr-Appellee Walgreens is an Illinois corporation with retail drug stores across the country that sell footwear, among other products. Defendant-Appellee Touchsport is a California corporation that, like Seaway, serves as a buyer’s agent and/or importer of footwear to retailers, including Walgreens.

[1236]*1236Seaway’s '263, '032, and '033 patents (collectively “the patents-in-suit”) claim designs for casual, lightweight footwear, which are typically referred to as “clogs.” The '263 patent application was filed on February 18, 2005, and issued on October 3, 2006. The '032 and '033 patents were filed as continuations-in-part of the '263 patent in February 2006, and both issued on June 26, 2007. It is undisputed that the '032 and '033 patents are “substantially the same as the '263 patent design” except that the heel strap is in a forward position overlying a portion of the clog upper in the '032 patent and that the heel strap is not part of the claimed design for the '033 patent.

A single Patent Office Examiner examined and allowed each of the three patents-in-suit. During prosecution of the '263 patent application, the examiner considered and found the '263 patent design patentable over: (a) four pages from the website of Crocs that depicted various models of Crocs clogs, including the Beach model clog; (b) five pages of photographs of the Crocs Beach model clog; and (c) a December 2002 archival version of the Crocs website, depicting various views of a Crocs clog. In the examination of the '263 patent application, the examiner did not have the benefit of the Crocs '789 patent, which depicted the Crocs Beach model clog, even though the '789 patent issued before the examination was concluded. For the '032 and '033 patent applications, the examiner considered and found the '032 and '033 designs patentable over the references considered during the '263 prosecution as well as the '789 patent.

On February 15, 2008, Seaway filed a complaint against Walgreens and Touchs-port in the United States District Court for the Southern District of Florida, alleging that they were infringing its '263, '032 and '033 patents. Seaway asserted that Touchsport had imported and continued to import shoes that infringed the Seaway patents and that Walgreens had sold and continued to sell the allegedly infringing shoes. Walgreens and Touchsport filed a motion for summary judgment on June 24, 2008, contending that Seaway’s patents were invalid as anticipated under 35 U.S.C. § 102(a) & (e) by the Crocs Beach and Cayman model clogs and/or the Crocs '789 patent, or as obvious under 35 U.S.C. § 103 in view of the Crocs Beach and Cayman model clogs and/or the Crocs '789 patent. Figures depicting the design in the '789 patent, and the design in the '263 patent, which is representative of the designs in the '032 and '033 patents, are set forth below.

Figure 1 in the '789 Patent

[[Image here]]

[1237]*1237 Figure 2 in the '263 Patent

On January 22, 2009, the district court granted summary judgment of anticipation, finding that the three Seaway patents were anticipated by the Crocs '789 patent. Int’l Seaway Trading Corp., 599 F.Supp.2d at 1317. The district court held that the ordinary observer test was the sole test of design patent invalidity under 35 U.S.C. § 102. Id. In granting summary judgment, the district court considered and compared the exterior portions of the designs of the patents-in-suit, but not the insoles of the designs, to the prior art. Id. at 1318-19. The district court concluded that comparison of the insoles was not required, holding “that the law requires a court to consider only those portions of the product that are visible during normal use, regardless of whether those portions are visible during the point of sale.” Id. at 1315. The court then explained its rationale:

When a shoe is in use, it’s [sic] insole is, obviously, hidden by the user’s foot. The sole of the shoe, however is sometimes visible while a person is sitting or walking. As such, this Court will not consider any aspects of the insoles of the shoes, but will consider the sole of the shoes as those are visible during use.

Id. The district court did not determine whether the patents-in-suit were invalid as obvious.

Seaway timely appealed, and we have jurisdiction under 28 U.S.C. § 1295(a)(1). Because this appeal is from a grant of summary judgment, we view the record in the light most favorable to the non-moving party (here Seaway). OddzOn Prods., Inc. v. Just Toys, Inc., 122 F.3d 1396, 1401 (Fed.Cir.1997). Anticipation is a question of fact. Akzo N.V. v. U.S. Int’l Trade Comm’n, 808 F.2d 1471, 1479 (Fed.Cir.1986).

DISCUSSION

I

Seaway first contends that the district court should have applied the point of novelty test in addition to the ordinary observer test during its anticipation analysis. Our decision in Egyptian Goddess, Inc. v. Swisa, Inc., 543 F.3d 665 (Fed.Cir.2008) (en banc), changed the test for infringement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
589 F.3d 1233, 93 U.S.P.Q. 2d (BNA) 1001, 2009 U.S. App. LEXIS 27648, 2009 WL 4842608, Counsel Stack Legal Research, https://law.counselstack.com/opinion/international-seaway-trading-corp-v-walgreens-corp-cafc-2009.